Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Aromatase inhibitor-associated musculoskeletal symptoms: incidence and associated factors.

Park JY, Lee SK, Bae SY, Kim J, Kim MK, Kil WH, Lee JE, Nam SJ.

J Korean Surg Soc. 2013 Nov;85(5):205-11. doi: 10.4174/jkss.2013.85.5.205. Epub 2013 Oct 25.

2.

Genetic variant in the osteoprotegerin gene is associated with aromatase inhibitor-related musculoskeletal toxicity in breast cancer patients.

Lintermans A, Van Asten K, Jongen L, Van Brussel T, Laenen A, Verhaeghe J, Vanderschueren D, Lambrechts D, Neven P.

Eur J Cancer. 2016 Mar;56:31-6. doi: 10.1016/j.ejca.2015.12.013. Epub 2016 Jan 19.

PMID:
26798969
3.

Arthralgia induced by endocrine treatment for breast cancer: A prospective study of serum levels of insulin like growth factor-I, its binding protein and oestrogens.

Lintermans A, Vanderschueren D, Verhaeghe J, Van Asten K, Jans I, Van Herck E, Laenen A, Paridaens R, Billen J, Pauwels S, Vermeersch P, Wildiers H, Christiaens MR, Neven P.

Eur J Cancer. 2014 Nov;50(17):2925-31. doi: 10.1016/j.ejca.2014.08.012. Epub 2014 Oct 7.

PMID:
25304297
4.

Aromatase inhibitor-associated arthralgia syndrome.

Burstein HJ.

Breast. 2007 Jun;16(3):223-34. Epub 2007 Mar 21. Review.

PMID:
17368903
5.

A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMI.

Lintermans A, Van Asten K, Wildiers H, Laenen A, Paridaens R, Weltens C, Verhaeghe J, Vanderschueren D, Smeets A, Van Limbergen E, Leunen K, Christiaens MR, Neven P.

Breast Cancer Res Treat. 2014 Jul;146(1):109-16. doi: 10.1007/s10549-014-2986-7. Epub 2014 May 11.

PMID:
24816806
6.

Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms?

Muslimani AA, Spiro TP, Chaudhry AA, Taylor HC, Jaiyesimi I, Daw HA.

Clin Breast Cancer. 2009 Feb;9(1):34-8. doi: 10.3816/CBC.2009.n.006.

PMID:
19299238
7.

Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors.

Mao JJ, Stricker C, Bruner D, Xie S, Bowman MA, Farrar JT, Greene BT, DeMichele A.

Cancer. 2009 Aug 15;115(16):3631-9. doi: 10.1002/cncr.24419.

8.

Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer.

Crew KD, Greenlee H, Capodice J, Raptis G, Brafman L, Fuentes D, Sierra A, Hershman DL.

J Clin Oncol. 2007 Sep 1;25(25):3877-83.

PMID:
17761973
9.

A prospective pilot study investigating the musculoskeletal pain in postmenopausal breast cancer patients receiving aromatase inhibitor therapy.

Robidoux A, Rich E, Bureau NJ, Mader S, Laperrière D, Bail M, Tremblay N, Patenaude M, Turgeon J.

Curr Oncol. 2011 Dec;18(6):285-94.

10.

A prospective study of aromatase inhibitor-associated musculoskeletal symptoms and abnormalities on serial high-resolution wrist ultrasonography.

Henry NL, Jacobson JA, Banerjee M, Hayden J, Smerage JB, Van Poznak C, Storniolo AM, Stearns V, Hayes DF.

Cancer. 2010 Sep 15;116(18):4360-7. doi: 10.1002/cncr.25385.

11.

The CIRAS study: a case control study to define the clinical, immunologic, and radiographic features of aromatase inhibitor-induced musculoskeletal symptoms.

Shanmugam VK, McCloskey J, Elston B, Allison SJ, Eng-Wong J.

Breast Cancer Res Treat. 2012 Jan;131(2):699-708. doi: 10.1007/s10549-011-1849-8. Epub 2011 Nov 11.

12.

Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy.

Kidwell KM, Harte SE, Hayes DF, Storniolo AM, Carpenter J, Flockhart DA, Stearns V, Clauw DJ, Williams DA, Henry NL.

Cancer. 2014 Aug 15;120(16):2403-11. doi: 10.1002/cncr.28756. Epub 2014 May 6.

13.

Aromatase inhibitor-associated musculoskeletal symptoms: etiology and strategies for management.

Henry NL, Giles JT, Stearns V.

Oncology (Williston Park). 2008 Nov 15;22(12):1401-8. Review.

14.

Adjuvant aromatase inhibitor therapy in early breast cancer: what factors lead patients to discontinue treatment?

Moscetti L, Agnese Fabbri M, Sperduti I, Fabrizio N, Frittelli P, Massari A, Pompei L, D'Auria G, Pofi E, Ruggeri EM.

Tumori. 2015 Sep-Oct;101(5):469-73. doi: 10.5301/tj.5000376. Epub 2015 Jun 13.

PMID:
26108239
15.

Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort.

Castel LD, Hartmann KE, Mayer IA, Saville BR, Alvarez J, Boomershine CS, Abramson VG, Chakravarthy AB, Friedman DL, Cella DF.

Cancer. 2013 Jul 1;119(13):2375-82. doi: 10.1002/cncr.28016. Epub 2013 Apr 10.

16.

Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case-control study.

Henry NL, Pchejetski D, A'Hern R, Nguyen AT, Charles P, Waxman J, Li L, Storniolo AM, Hayes DF, Flockhart DA, Stearns V, Stebbing J.

Br J Cancer. 2010 Jul 27;103(3):291-6. doi: 10.1038/sj.bjc.6605768. Epub 2010 Jul 6.

17.

A prospective study of aromatase inhibitor therapy, vitamin D, C-reactive protein and musculoskeletal symptoms.

Helzlsouer KJ, Gallicchio L, MacDonald R, Wood B, Rushovich E.

Breast Cancer Res Treat. 2012 Jan;131(1):277-85. doi: 10.1007/s10549-011-1729-2. Epub 2011 Sep 9.

PMID:
21904883
18.

Managing arthralgia in a postmenopausal woman taking an aromatase inhibitor for hormonesensitive early breast cancer: a case study.

Bryce J, Bauer M, Hadji P.

Cancer Manag Res. 2012;4:105-11. doi: 10.2147/CMAR.S29448. Epub 2012 Mar 29.

19.

Acupuncture for treating aromatase inhibitor-related arthralgia in breast cancer: a systematic review and meta-analysis.

Chien TJ, Liu CY, Chang YF, Fang CJ, Hsu CH.

J Altern Complement Med. 2015 May;21(5):251-60. doi: 10.1089/acm.2014.0083. Epub 2015 Apr 27. Review.

20.

Aromatase inhibitor associated musculoskeletal symptoms are associated with reduced physical activity among breast cancer survivors.

Brown JC, Mao JJ, Stricker C, Hwang WT, Tan KS, Schmitz KH.

Breast J. 2014 Jan-Feb;20(1):22-8. doi: 10.1111/tbj.12202. Epub 2013 Oct 25.

Supplemental Content

Support Center